Gentherm (THRM) Misses Q2 EPS by 3c, provides guidance

Gentherm (NASDAQ: THRM) reported Q2 EPS of $0.54, $0.03 worse than the analyst estimate of $0.57. Revenue for the quarter came in at $375 million versus the consensus estimate of $360.43 million.

Guidance for full year 2025 as of July 24, 2025 is provided below:

Product Revenues: $1.43B – $1.5B
Adjusted EBITDA Margin Rate: 11.7% – 12.5%
Full-year Adjusted Effective Tax Rate 26% – 29%
Capital Expenditures: $55M – $65M

For earnings history and earnings-related data on Gentherm (THRM) click here.

You May Also Be Interested In

• Apple suing OpenAI over alleged misappropriation of trade secrets
• Niagen Bioscience files to sell up to $50M in common stock
• CORVEX (MOVE) files for 53.39M share offering by selling stockholders